Mycobacterium intracellulare pulmonary disease with endobronchial caseation in a patient treated with methotrexate

Tuberculosis and Respiratory Diseases

Volumn 75, Issue 1, 2013, Pages 28-31

  Park, Jin Sun ^a   Jung, Eul Sik ^a   Choi, Woosuk ^a   Park, Soo Yong ^a   Rim, Min Young ^a   Yu, Inku ^a   Park, Hyeonsu ^a   Lee, Sang Min ^a   Park, Jeong Woong ^a   Jeong, Sung Hwan ^a   Lee, Sang Pyo ^a   Park, Sanghui ^b  

^a Gachon University   (South Korea)

^b Ewha Womans University School of Medicine   (South Korea)

Author keywords

Arthiritis, rheumatoid; Bronchial diseases; Methotrexate; Nontuberculous mycobacteria; Tuberculosis, pulmonary

Indexed keywords

C REACTIVE PROTEIN; ETHAMBUTOL; HYDROXYCHLOROQUINE SULFATE; ISONIAZID; METHOTREXATE; NABUMETONE; PARACETAMOL; PYRAZINAMIDE; RIFAMPICIN;

ADULT; ANOREXIA; ARTICLE; BACTERIUM CULTURE; BODY TEMPERATURE; BREATHING RATE; BRONCHOSCOPY; BRONCHUS BIOPSY; CASE REPORT; DISEASE EXACERBATION; DRUG WITHDRAWAL; DYSPNEA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEART RHYTHM; HUMAN; LUNG INFILTRATE; LUNG TUBERCULOSIS; LYMPHADENOPATHY; MYCOBACTERIUM INTRACELLULARE; NIGHT SWEAT; RHEUMATOID ARTHRITIS; THORAX PAIN; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 84882808087     PISSN: 17383536     EISSN: None     Source Type: Journal    
DOI: 10.4046/trd.2013.75.1.28     Document Type: Article

References (15)

1. Aletaha D, Smolen JS. The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses. Rheumatology (Oxford) 2002;41:1367-74. (Pubitemid 36004312)
2. Pincus T, Yazici Y, Sokka T, Aletaha D, Smolen JS. Methotrexate as the "anchor drug" for the treatment of early rheumatoid arthritis. Clin Exp Rheumatol 2003;21(5 Suppl 31):S179-85. (Pubitemid 37265610)
3. Koh WJ, Kwon OJ, Jeon K, Kim TS, Lee KS, Park YK, et al. Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. Chest 2006;129:341-8. (Pubitemid 43289853)
4. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175:367-416.
5. Shih JY, Wang HC, Chiang IP, Yang PC, Luh KT. Endobronchial lesions in a non-AIDS patient with disseminated Mycobacterium avium-intracellulare infection. Eur Respir J 1997;10:497-9.
6. Mehle ME, Adamo JP, Mehta AC, Wiedemann HP, Keys T, Longworth DL. Endobronchial Mycobacterium avium-intracellulare infection in a patient with AIDS. Chest 1989;96:199-201. (Pubitemid 19176444)
7. Lee JH, Son KS, Park JH, Kim JC, Lee HW, Kim CH. Mycobacterium avium infection presenting as endobronchial lesions in an immunocompetent patient. Tuberc Respir Dis 2006;60:571-5. (Pubitemid 44343378)
8. O'Brien RJ, Geiter LJ, Snider DE Jr. The epidemiology of nontuberculous mycobacterial diseases in the United States: results from a national survey. Am Rev Respir Dis 1987;135:1007-14. (Pubitemid 18021482)
9. Rosenzweig SD, Holland SM. Defects in the interferon-gamma and interleukin-12 pathways. Immunol Rev 2005;203:38-47.
10. Kolokotronis A, Avramidou E, Zaraboukas T, Mandraveli K, Alexiou S, Antoniades D. Oral tuberculosis associated with a treatment with anti-rheumatic drugs. J Oral Pathol Med 2006;35:123-5.
11. Lee JY, Yi CA, Kim TS, Kim H, Kim J, Han J, et al. CT scan features as predictors of patient outcome after bronchial intervention in endobronchial TB. Chest 2010;138:380-5.
12. Watanabe Y, Murakami S, Iwa T. Bronchial stricture due to endobronchial tuberculosis. Thorac Cardiovasc Surg 1988;36:27-32.
13. Iikuni N, Kitahama M, Ohta S, Okamoto H, Kamatani N, Nishinarita M. Evaluation of Pneumocystis pneumonia infection risk factors in patients with connective tissue disease. Mod Rheumatol 2006;16:282-8. (Pubitemid 44575253)
14. Luis M, Pacheco-Tena C, Cazarin-Barrientos J, Lino-Perez L, Goycochea MV, Vazquez-Mellado J, et al. Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study. Arthritis Rheum 1999;42:2160-5. (Pubitemid 30263600)
15. Visser K, Katchamart W, Loza E, Martinez-Lopez JA, Salliot C, Trudeau J, et al. Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Ann Rheum Dis 2009;68:1086-93.